ClinicalTrials.gov record
Recruiting Phase 1 Interventional Accepts healthy volunteers

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT07258849

Public ClinicalTrials.gov record NCT07258849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 2:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Multicenter, Randomized, Placebo-Controlled, Investigator- and Participant-Blinded, Single- and Multiple-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY4213663 in Healthy Participants, and Two Open-Label, Multiple-Dose Evaluations of LY4213663 in Patients With Rheumatoid Arthritis.

Study identification

NCT ID
NCT07258849
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
141 participants

Conditions and interventions

Interventions

  • LY4213663 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2025
Primary completion
Feb 29, 2028
Completion
Feb 29, 2028
Last update posted
May 3, 2026

2025 โ€“ 2028

United States locations

U.S. sites
9
U.S. states
4
U.S. cities
9
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207 Recruiting
Arizona Research Center Phoenix Arizona 85053 Recruiting
Clinical Research of West Florida, Inc. (Clearwater) Clearwater Florida 33765 Not yet recruiting
GNP Research at Mark Jaffe, MD Cooper City Florida 33024 Recruiting
Fortrea Clinical Research Unit Daytona Beach Florida 32117 Recruiting
AGA Clinical Trials Hialeah Florida 33012 Recruiting
Advanced Pharma CR, LLC Miami Florida 33417 Recruiting
Floridian Clinical Research Miami Lakes Florida 33016 Recruiting
Oasis Clinical Research Las Vegas Nevada 89121 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07258849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 ยท Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07258849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record โ†’